Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US

Our Bureau

Asep Medical Holdings Inc. (“Asep Inc.” or the “Company“) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company’s AI-based sepsis diagnostic technology, called SepsetER TM, has received successful patent approval in the United States. The Company received confirmation from its attorneys of its US Patent Application No. 16/279788, which has been subsequently validated in […]

Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy USA – English 

Our Bureau

Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (‘Calliditas’) today announced that its partner Everest Medicines (HKEX: 1952.HK) (‘Everest’) announced that China’s National Medical Products Administration (NMPA) has approved Nefecon® for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression. China has the highest prevalence of primary glomerular diseases in the world […]

Everest Medicines Announces China NMPA’s Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients USA – English 

Our Bureau

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that China’s National Medical Products Administration (NMPA) has approved Nefecon® for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression. Nefecon® was the […]

Manhattan Psychology Group Joins ARC Health

Our Bureau

ARC Health, a Thurston Group portfolio company, announces the acquisition of Manhattan Psychology Group, PC (MPG), a distinguished behavioral health practice with multiple locations catering to the Greater New York City Metro Area. Their physical offices are located on the Upper West Side in Manhattan and Long Island City, Queens, and their broad spectrum of services encompass […]

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

Our Bureau

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces the publication of preclinical research in Science Advances, highlighting the potential of its Tie2-activating antibody program, PMC-403, in treating Idiopathic Systemic Capillary Leak Syndrome (ISCLS). The results underscore the novel mechanism of action, […]

Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services

Our Bureau

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services. This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will help identify serious health conditions sooner, allowing for earlier intervention […]

Pharmactive Biotech Products Joins the B Corp Community

Our Bureau

Pharmactive Biotech Products, SLU, a pioneer in the research and development of high-quality natural extracts, announces its establishment as a certified B Corporation. This designation reaffirms the company’s dedication to upholding high standards in terms of social and environmental performance, transparency, and business excellence. The B Corp standard measures management […]

MediBuddy and Aditya Birla Housing Finance Launch Exclusive Healthcare Plan for Housing Finance Customers

Our Bureau

MediBuddy, India’s largest digital healthcare platform, and Aditya Birla Housing Finance Limited (ABHFL), a prominent player in the housing finance sector, have collaboratively introduced exclusive healthcare advantages for the customers of ABHFL. This strategic partnership aims to offer affordable and accessible healthcare services to customers through an exclusive MediBuddy plan. […]

Agilus Diagnostics launches advanced laboratory in Bongaigaon

Our Bureau

Agilus Diagnostics, a subsidiary of Fortis Healthcare Limited., today announced the launch of a new laboratory in Bongaigaon, Assam. The advanced laboratory has the capacity to process 25,000+ samples in a month ranging from simple routine tests to semi-specialized and specialized tests. Recognizing the rising demand for quality diagnostic services, […]

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

Our Bureau

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces the publication of preclinical research in Science Advances, highlighting the potential of its Tie2-activating antibody program, PMC-403, in treating Idiopathic Systemic Capillary Leak Syndrome (ISCLS). The results underscore the novel mechanism of action, […]

Subscribe Now